Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API’s, Intermediates and Nutraceutical ingredients
Financial Results:
Divi’s Laboratories Ltd reported Revenues for Q4FY24 of ₹2,303.00 Crores up from ₹1,951.00 Crore year on year, a rise of 18.04%.
Total Expenses for Q4FY24 of ₹1,669.00 Crores up from ₹1,551.00 Crores year on year, a rise of 7.61%.
Consolidated Net Profit of ₹538.00 Crores up 67.6% from ₹321.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹20.27, up 67.66% from ₹12.09 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.